While EPHA1 and EPHA2 showed significantly increased expression in CRC specimens [46,47,48], they were also associated with lower stage tumors [46,47,48], and, in the case of EPHA1, with longer patient OS [48]. This evidence concerns the gene EPHA1 and colorectal carcinoma.